Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 338

1.

Yet another susceptibility variant for ALL: what's next?

Schmiegelow K.

Blood. 2019 Feb 14;133(7):628-629. doi: 10.1182/blood-2018-12-891564. No abstract available.

PMID:
30765495
2.

Low burden of minimal residual disease prior to transplantation in children with very high risk acute lymphoblastic leukaemia: The NOPHO ALL2008 experience.

Ifversen M, Turkiewicz D, Marquart HV, Winiarski J, Buechner J, Mellgren K, Arvidson J, Rascon J, Körgvee LT, Madsen HO, Abrahamsson J, Lund B, Jonsson OG, Heilmann C, Heyman M, Schmiegelow K, Vettenranta K.

Br J Haematol. 2019 Jan 24. doi: 10.1111/bjh.15761. [Epub ahead of print]

PMID:
30680711
3.

Endocrine Late Effects in Survivors of Cancer in Adolescence and Young Adulthood: A Danish Population-Based Cohort Study.

Jensen MV, Rugbjerg K, de Fine Licht S, Johansen C, Schmiegelow K, Andersen KK, Winther JF.

JAMA Netw Open. 2018 Jun 1;1(2):e180349. doi: 10.1001/jamanetworkopen.2018.0349.

4.

Posterior reversible encephalopathy syndrome in children with acute lymphoblastic leukemia: Clinical characteristics, risk factors, course, and outcome of disease.

Anastasopoulou S, Eriksson MA, Heyman M, Wang C, Niinimäki R, Mikkel S, Vaitkevičienė GE, Johannsdottir IM, Myrberg IH, Jonsson OG, Als-Nielsen B, Schmiegelow K, Banerjee J, Harila-Saari A, Ranta S.

Pediatr Blood Cancer. 2018 Dec 27:e27594. doi: 10.1002/pbc.27594. [Epub ahead of print]

PMID:
30592147
5.

An integrated transcriptome analysis in T-cell acute lymphoblastic leukemia links DNA methylation subgroups to dysregulated TAL1 and ANTP homeobox gene expression.

Haider Z, Larsson P, Landfors M, Köhn L, Schmiegelow K, Flaegstad T, Kanerva J, Heyman M, Hultdin M, Degerman S.

Cancer Med. 2019 Jan;8(1):311-324. doi: 10.1002/cam4.1917. Epub 2018 Dec 21.

6.

Minimal residual disease quantification by flow cytometry provides reliable risk stratification in T-cell acute lymphoblastic leukemia.

Modvig S, Madsen HO, Siitonen SM, Rosthøj S, Tierens A, Juvonen V, Osnes LTN, Vålerhaugen H, Hultdin M, Thörn I, Matuzeviciene R, Stoskus M, Marincevic M, Fogelstrand L, Lilleorg A, Toft N, Jónsson OG, Pruunsild K, Vaitkeviciene G, Vettenranta K, Lund B, Abrahamsson J, Schmiegelow K, Marquart HV.

Leukemia. 2018 Dec 14. doi: 10.1038/s41375-018-0307-6. [Epub ahead of print]

PMID:
30552401
7.

Maternal use of hormonal contraception and risk of childhood leukaemia - Authors' reply.

Hargreave M, Mørch LS, Andersen KK, Winther JF, Schmiegelow K, Kjaer SK.

Lancet Oncol. 2018 Dec;19(12):e659. doi: 10.1016/S1470-2045(18)30849-0. No abstract available.

PMID:
30507419
8.

Trypsin encoding PRSS1-PRSS2 variation influence the risk of asparaginase-associated pancreatitis in children with acute lymphoblastic leukemia: a Ponte di Legno toxicity working group report.

Wolthers BO, Frandsen TL, Patel CJ, Abaji R, Attarbaschi A, Barzilai S, Colombini A, Escherich G, Grosjean M, Krajinovic M, Larsen E, Liang DC, Möricke A, Rasmussen KK, Samarasinghe S, Silverman LB, van der Sluis IM, Stanulla M, Tulstrup M, Yadav R, Yang W, Zapotocka E, Gupta R, Schmiegelow K.

Haematologica. 2018 Nov 22. pii: haematol.2018.199356. doi: 10.3324/haematol.2018.199356. [Epub ahead of print]

9.

Genetic predisposition to PEG-asparaginase hypersensitivity in children treated according to NOPHO ALL2008.

Højfeldt SG, Wolthers BO, Tulstrup M, Abrahamsson J, Gupta R, Harila-Saari A, Heyman M, Henriksen LT, Jónsson ÒG, Lähteenmäki PM, Lund B, Pruunsild K, Vaitkeviciene G, Schmiegelow K, Albertsen BK; Nordic Society of Paediatric Haematology Oncology (NOPHO) group.

Br J Haematol. 2019 Feb;184(3):405-417. doi: 10.1111/bjh.15660. Epub 2018 Nov 18.

PMID:
30450575
10.

Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2018 Update.

Relling MV, Schwab M, Whirl-Carrillo M, Suarez-Kurtz G, Pui CH, Stein CM, Moyer AM, Evans WE, Klein TE, Antillon-Klussmann FG, Caudle KE, Kato M, Yeoh AEJ, Schmiegelow K, Yang JJ.

Clin Pharmacol Ther. 2018 Nov 17. doi: 10.1002/cpt.1304. [Epub ahead of print]

PMID:
30447069
11.

Methotrexate polyglutamate levels and co-distributions in childhood acute lymphoblastic leukemia maintenance therapy.

Nersting J, Nielsen SN, Grell K, Paerregaard M, Abrahamsson J, Lund B, Jonsson OG, Pruunsild K, Vaitkeviciene G, Kanerva J, Schmiegelow K; Nordic Society of Paediatric Haematology and Oncology (NOPHO).

Cancer Chemother Pharmacol. 2019 Jan;83(1):53-60. doi: 10.1007/s00280-018-3704-7. Epub 2018 Oct 15.

PMID:
30324220
12.

Neonatal Inflammatory Markers Are Associated with Childhood B-cell Precursor Acute Lymphoblastic Leukemia.

Søegaard SH, Rostgaard K, Skogstrand K, Wiemels JL, Schmiegelow K, Hjalgrim H.

Cancer Res. 2018 Sep 15;78(18):5458-5463. doi: 10.1158/0008-5472.CAN-18-0831.

PMID:
30217873
13.

Insulin-dependent diabetes: A chronic complication to acute pancreatitis in childhood acute lymphoblastic leukemia.

Wolthers BO, Mogensen PR, Frandsen TL, Abrahamsson J, Behrendtz M, Heyman M, Lohi O, Norén-Nyström U, Ruud E, Schmiegelow K.

Pediatr Blood Cancer. 2019 Jan;66(1):e27437. doi: 10.1002/pbc.27437. Epub 2018 Sep 14.

PMID:
30216644
14.

NT5C2 germline variants alter thiopurine metabolism and are associated with acquired NT5C2 relapse mutations in childhood acute lymphoblastic leukaemia.

Tulstrup M, Grosjean M, Nielsen SN, Grell K, Wolthers BO, Wegener PS, Jonsson OG, Lund B, Harila-Saari A, Abrahamsson J, Vaitkeviciene G, Pruunsild K, Toft N, Holm M, Hulegårdh E, Liestøl S, Griskevicius L, Punab M, Wang J, Carroll WL, Zhang Z, Dalgaard MD, Gupta R, Nersting J, Schmiegelow K.

Leukemia. 2018 Dec;32(12):2527-2535. doi: 10.1038/s41375-018-0245-3. Epub 2018 Sep 10.

PMID:
30201983
15.

Maternal use of hormonal contraception and risk of childhood leukaemia: a nationwide, population-based cohort study.

Hargreave M, Mørch LS, Andersen KK, Winther JF, Schmiegelow K, Kjaer SK.

Lancet Oncol. 2018 Oct;19(10):1307-1314. doi: 10.1016/S1470-2045(18)30479-0. Epub 2018 Sep 6.

PMID:
30197174
16.

[Insufficient evidence in prophylactic therapy of chemotherapy-induced nausea and vomiting in children and adolescents].

Eliasen A, Callesen MT, Dalhoff KP, Rechnitzer C, Schmiegelow K, Schrøder H, Tuckuviene R, Holst H.

Ugeskr Laeger. 2018 Aug 27;180(35). pii: V11170851. Danish.

PMID:
30152323
17.

Putative new childhood leukemia cancer predisposition syndrome caused by germline bi-allelic missense mutations in DDX41.

Diness BR, Risom L, Frandsen TL, Hansen B, Andersen MK, Schmiegelow K, Wadt KAW.

Genes Chromosomes Cancer. 2018 Dec;57(12):670-674. doi: 10.1002/gcc.22680. Epub 2018 Oct 11.

PMID:
30144193
18.

Pediatric cancer families' participation in whole-genome sequencing research in Denmark: Parent perspectives.

Byrjalsen A, Stoltze U, Wadt K, Hjalgrim LL, Gerdes AM, Schmiegelow K, Wahlberg A.

Eur J Cancer Care (Engl). 2018 Nov;27(6):e12877. doi: 10.1111/ecc.12877. Epub 2018 Jul 17.

PMID:
30016002
19.

Comparing osteonecrosis clinical phenotype, timing, and risk factors in children and young adults treated for acute lymphoblastic leukemia.

Mogensen SS, Harila-Saari A, Mäkitie O, Myrberg IH, Niinimäki R, Vestli A, Hafsteinsdottir S, Griškevicius L, Saks K, Hallböök H, Retpen J, Helt LR, Toft N, Schmiegelow K, Frandsen TL; Nordic Society of Paediatric Haematology and Oncology (NOPHO) group.

Pediatr Blood Cancer. 2018 Oct;65(10):e27300. doi: 10.1002/pbc.27300. Epub 2018 Jun 26.

PMID:
29943905
20.

Sperm DNA Integrity is Unaffected by Thiopurine Treatment in Men With Inflammatory Bowel Disease.

Grosen A, Nersting J, Bungum M, Christensen LA, Schmiegelow K, Spanò M, Julsgaard M, Cordelli E, Leter G, Larsen PB, Hvas CL, Kelsen J.

J Crohns Colitis. 2019 Jan 1;13(1):3-11. doi: 10.1093/ecco-jcc/jjy086.

PMID:
29917107

Supplemental Content

Loading ...
Support Center